Featured News
604Wire StoriesJumio Announces Highest Sales Quarter Ever Powered by Financial Services and Healthcare Initiatives
Q2 highlights include launch of San Diego Innovation Lab, key executive hires and industry recognition for KYX Platform PALO ALTO, Calif.–(BUSINESS WIRE)–Jumio,...
- 525Wire Stories
2022 Database of Home Furnishings Retailers in Asia – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Database of Home Furnishings Retailers in Asia” database has been added to ResearchAndMarkets.com’s offering. The Database of Home Furnishings Retailers...
- 615Wire Stories
The Fifth CIIE Benefits Countries Along the Belt and Road
SHANGHAI–(BUSINESS WIRE)–$CHINA #china–A major platform for international procurement, investment promotion, cultural exchanges and open cooperation, the China International Import Expo (CIIE) has...
- 579News
ViewQwest Continues SASE Market Expansion in SEA with new HK Point of Presence (PoP)
Expanded coverage to serve growing regional and global customer base SINGAPORE – Media OutReach – 26 July 2022 – Leading telecommunications, network,...
- 799Wire Stories
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and the SEA countries
SINGAPORE–(BUSINESS WIRE)–#HD204—Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas Pharmaceuticals Limited (hereafter referred to as “Intas”) today announced...
- 596Wire Stories
Seagen and Astellas Announce Positive Topline Results For PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) as First-Line Treatment for Advanced Urothelial Cancer
– Companies plan to discuss results with regulatory authorities – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE:4503,...
- 483News
Fujitsu Global Delivery Center Philippines awarded with Best Places to Work Certification
MANILA, PHILIPPINES – Media OutReach – 26 July 2022 – Fujitsu’s Global Delivery Center in the Philippines (GDC) has been awarded with...
- 575News
Onfido invests in new Bug Bounty program, fortifying security and reliability in the Real Identity Platform
Onfido partners with YesWeHack and its community of 40,000 cyber researchers to pentest the Real Identity Platform, further strengthening its security SINGAPORE...
- 559Wire Stories
SMOORE Opens First PMTA Testing Laboratory in China
SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China’s first non-clinical full-scale testing laboratory for Premarket...
- 468News
Infor Names Isabella Kusumawati Vice President and Managing Director for Southeast Asia and Korea
Asian industry veteran chosen to helm most diverse region in Asia Pacific SINGAPORE – Media OutReach – 26 July 2022 – Infor,...
- 553Wire Stories
GEM, a Leading Green Enterprise in China, will land on the Swiss Exchange
SHENZHEN, China–(BUSINESS WIRE)–GEM (stock code: 002340), a company listed on the Shenzhen Stock Exchange, announced that on June 22, 2022, that the...
